4//SEC Filing
Barclay Alec 4
Accession 0000899243-22-008057
CIK 0001492674other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:00 PM ET
Size
8.7 KB
Accession
0000899243-22-008057
Insider Transaction Report
Form 4
Barclay Alec
SVP, Operations
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-02-24−168,488→ 336,976 total→ Common Stock (168,488 underlying) - Exercise/Conversion
Common Stock
2021-02-24+168,488→ 247,633 total - Tax Payment
Common Stock
2021-02-24$0.45/sh−88,878$39,888→ 158,755 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]88,878 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On February 24, 2021 the reporting person was granted 505,464 RSU's that vest in three equal annual installments commencing on February 24, 2022.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001734339
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:00 PM ET
- Size
- 8.7 KB